Michell A Clark

Title: The Innovations of Michell A Clark

Introduction

Michell A Clark is a notable inventor based in Crows Nest, Australia. He has made significant contributions to the field of biotechnology, particularly in the development of proteins that play a crucial role in cancer research and treatment. His work has implications for understanding tumor invasion and metastasis.

Latest Patents

Michell A Clark holds a patent for Human PAI-2, also known as Minactivin. This protein inactivator of urokinase-type plasminogen activator has been identified as a natural inactivator associated with invasive tumors. The patent outlines methods for producing minactivin through the cultivation of minactivin-producing cells in vitro. It also details the purification of biologically active native minactivin and peptides derived from it, along with their amino acid sequences. Furthermore, the specification includes methods for producing PAI-2 using recombinant DNA technology, characterizing the PAI-2 gene sequence, and expressing and purifying large quantities of biologically active PAI-2 from a recombinant host.

Career Highlights

Throughout his career, Michell A Clark has worked with prominent organizations such as Biotechnology Australia Pty Ltd and The Australian National University. His experience in these institutions has allowed him to advance his research and contribute to significant scientific advancements.

Collaborations

Michell A Clark has collaborated with esteemed colleagues, including Ross W Stephens and Jeffrey P Golder. These partnerships have further enriched his research and innovation in the field of biotechnology.

Conclusion

Michell A Clark's contributions to the field of biotechnology, particularly through his patent on Human PAI-2, highlight his role as an influential inventor. His work continues to impact cancer research and treatment methodologies.